Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 821569, 12 pages
http://dx.doi.org/10.1155/2014/821569
Research Article

Caffeamide 36-13 Regulates the Antidiabetic and Hypolipidemic Signs of High-Fat-Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production

1Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung City 40402, Taiwan
2Department of Biotechnology, Asia University, Taichung City 41354, Taiwan
3Department of Internal Medicine, Fengyuan Hospital, Ministry of Health and Welfare, Fengyuan District, Taichung City 42055, Taiwan
4Graduate Institute of Pharmaceutical Science and Technology, College of Health Science, Central Taiwan University of Science and Technology, No. 666 Buzih Road, Beitun District, Taichung City 40601, Taiwan

Received 19 May 2014; Accepted 3 July 2014; Published 20 July 2014

Academic Editor: Cicero L. T. Chang

Copyright © 2014 Yueh-Hsiung Kuo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. O'Rahilly, R. C. Turner, and D. R. Matthews, “Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes,” The New England Journal of Medicine, vol. 318, no. 19, pp. 1225–1230, 1988. View at Publisher · View at Google Scholar · View at Scopus
  2. C. R. Kahn, “Banting lecture: insulin action, diabetogenes, and the cause of type II diabetes,” Diabetes, vol. 43, no. 8, pp. 1066–1084, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Petro, J. Cotter, D. A. Cooper, J. C. Peters, S. J. Surwit, and R. S. Surwit, “Fat, carbohydrate and calories in the development of diabetes and obesity in the C57BL/6J mouse,” Metabolism, vol. 53, no. 4, pp. 454–457, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Guo, E. Kong, and M. Meydani, “Dietary polyphenols, inflammation, and cancer,” Nutrition and Cancer, vol. 61, no. 6, pp. 807–810, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Wongcharoen and A. Phrommintikul, “The protective role of curcumin in cardiovascular diseases,” International Journal of Cardiology, vol. 133, no. 2, pp. 145–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Hwang, D. Y. Kwon, and S. H. Yoon, “AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols,” New Biotechnology, vol. 26, no. 1-2, pp. 17–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Wojciechowski, D. Juric, X. L. Louis et al., “Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats,” Journal of Nutrition, vol. 140, no. 5, pp. 962–968, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Morimoto, Y. Sunagawa, T. Kawamura et al., “The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats,” The Journal of Clinical Investigation, vol. 118, no. 3, pp. 868–878, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. E. S. Lee, K. Uhm, Y. M. Lee et al., “CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cells,” Biochemical and Biophysical Research Communications, vol. 361, no. 4, pp. 854–858, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Weng, H. Chiu, Y. Lin, T. Chi, Y. Kuo, and M. Su, “Antihyperglycemic effect of a caffeamide derivative, KS370G, in normal and diabetic mice,” Journal of Agricultural and Food Chemistry, vol. 58, no. 18, pp. 10033–10038, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Weng, S. Chuang, Y. Lin et al., “Caffeic acid phenylethyl amide protects against the metabolic consequences in diabetes mellitus induced by diet and streptozocin,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 984780, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Mueckler, “Facilitative glucose transporters,” European Journal of Biochemistry, vol. 219, no. 3, pp. 713–725, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. N. J. Bryant, R. Govers, and D. E. James, “Regulated transport of the glucose transporter GLUT4,” Nature Reviews Molecular Cell Biology, vol. 3, no. 4, pp. 267–277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Lee, J. Ryu, R. P. Souto, P. F. Pilch, and C. Y. Jung, “Separation and partial characterization of three distinct intracellular GLUT4 compartments in rat adipocytes. Subcellular fractionation without homogenization,” The Journal of Biological Chemistry, vol. 274, no. 53, pp. 37755–37762, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. R. T. Watson and J. E. Pessin, “Intracellular organization of insulin signaling and GLUT4 translocation,” Recent Progress in Hormone Research, vol. 56, pp. 175–193, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Sujatha, S. Anand, K. N. Sangeetha et al., “Biological evaluation of (3β)-STIGMAST-5-EN-3-OL as potent anti-diabetic agent in regulating glucose transport using in vitro model,” International Journal of Diabetes Mellitus, vol. 2, no. 2, pp. 101–109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Ono, H. Shimano, R. Katagiri et al., “Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement,” Diabetes, vol. 52, no. 12, pp. 2905–2913, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Foretz, N. Toleux, B. Guigas et al., “Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases,” Medecine/Sciences, vol. 22, no. 4, pp. 381–388, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Viollet, L. Lantier, J. Devin-Leclerc et al., “Targeting the AMPK pathway for the treatment of type 2 diabetes,” Frontiers in Bioscience, vol. 14, no. 9, pp. 3380–3400, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Zhou, R. Myers, Y. Li et al., “Role of AMP-activated protein kinase in mechanism of metformin action,” The Journal of Clinical Investigation, vol. 108, no. 8, pp. 1167–1174, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. S. C. Stein, A. Woods, N. A. Jones, M. D. Davison, and D. Cabling, “The regulation of AMP-activated protein kinase by phosphorylation,” Biochemical Journal, vol. 345, part 3, pp. 437–443, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Shih, C. Lin, and W. Lin, “Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet,” Diabetes Research and Clinical Practice, vol. 81, no. 2, pp. 134–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Shih, C. Lin, and J. Wu, “Eriobotrya japonica improves hyperlipidemia and reverses insulin resistance in high-fat-fed mice,” Phytotherapy Research, vol. 24, no. 12, pp. 1769–1780, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. W. Shen, C. S. Jones, N. Kalchayanand, M. J. Zhu, and M. Du, “Effect of dietary α-lipoic acid on growth, body composition, muscle pH, and AMP-activated protein kinase phosphorylation in mice,” Journal of Animal Science, vol. 83, no. 11, pp. 2611–2617, 2005. View at Google Scholar · View at Scopus
  25. R. S. Surwit, A. E. Petro, P. Parekh, and S. Collins, “Low plasma leptin in response to dietary fat in diabetes- and obesity- prone mice,” Diabetes, vol. 46, no. 9, pp. 1516–1520, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. R. A. Harte, E. A. Kirk, M. E. Rosenfeld, and R. G. LeBoeuf, “Initiation of hyperinsulinemia and hyperleptinemia is diet dependent in C57BL/6 mice,” Hormone and Metabolic Research, vol. 31, no. 10, pp. 570–575, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Arner, “Insulin resistance in type 2 diabetes: role of fatty acids,” Diabetes/Metabolism Research and Reviews, vol. 18, no. 2, pp. S5–S9, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. M. S. Winzell and B. Ahrèn, “The high-fat diet mouse: a model for studying mechanisms and type 2 diabetes,” Diabetes, vol. 53, supplement 3, pp. S215–S219, 2004. View at Google Scholar
  29. M. A. Iglesias, J. M. Ye, G. Frangioudakis et al., “AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats,” Diabetes, vol. 51, no. 10, pp. 2886–2894, 2002. View at Google Scholar
  30. J. Ye, N. B. Ruderman, and E. W. Kraegen, “AMP-activated protein kinase and malonyl-CoA: targets for treating insulin resistance?” Drug Discovery Today: Therapeutic Strategies, vol. 2, no. 2, pp. 157–163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Minokoshi, C. R. Kahn, and B. B. Kahn, “Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis,” The Journal of Biological Chemistry, vol. 278, no. 36, pp. 33609–33612, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Huang and M. P. Czech, “The GLUT4 Glucose Transporter,” Cell Metabolism, vol. 5, no. 4, pp. 237–252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Fujii, R. C. Ho, Y. Manabe et al., “Ablation of AMP-activated protein kinase α 2 activity exacerbates insulin resistance induced by high-fat feeding of mice,” Diabetes, vol. 57, no. 11, pp. 2958–2966, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Bergeron, S. F. Previs, G. W. Cline et al., “Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese zucker rats,” Diabetes, vol. 50, no. 5, pp. 1076–1082, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Pold, L. S. Jensen, N. Jessen et al., “Long-term AICAR administration and exercise prevents diabetes in ZDF rats,” Diabetes, vol. 54, no. 4, pp. 928–934, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Cool, B. Zinker, W. Chiou et al., “Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome,” Cell Metabolism, vol. 3, no. 6, pp. 403–416, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Kurukulasuriya, J. T. Link, D. J. Madar et al., “Prospects for pharmacologic inhibition of hepatic glucose production,” Current Medicinal Chemistry, vol. 10, no. 2, pp. 99–121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. J. M. Berg, J. L. Tymoczko, and L. Stryer, “Glycolysis and glyconeogenesis,” in Stryer Biochemistry, J. M. Berg and J. L. Tymoczko, Eds., pp. 425–464, WH Freeman, New York, NY, USA, 2001. View at Google Scholar
  39. L. Guignot and G. Mithieux, “Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat,” The American Journal of Physiology, vol. 277, no. 6, part 1, pp. E984–E989, 1999. View at Google Scholar · View at Scopus
  40. D. Thiebaud, E. Jacot, R. A. DeFronzo, E. Maeder, E. Jequier, and J. P. Felber, “The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man,” Diabetes, vol. 31, no. 11, pp. 957–963, 1982. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Sarwar, P. Gao, S. R. Seshasai et al., “Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies,” The Lancet, vol. 375, no. 9733, pp. 2215–2222, 2010. View at Publisher · View at Google Scholar
  42. M. Kobayashi, Y. Matsuda, H. Iwai et al., “Coffee improves insulin-stimulated Akt phosphorylation in liver and skeletal muscle in diabetic KK-Ay mice,” Journal of Nutritional Science and Vitaminology, vol. 58, no. 6, pp. 408–414, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Musi, “AMP-activated protein kinase and type 2 diabetes,” Current Medicinal Chemistry, vol. 13, no. 5, pp. 583–589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Staels, J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J. Fruchart, “Mechanism of action of fibrates on lipid and lipoprotein metabolism,” Circulation, vol. 98, no. 19, pp. 2088–2093, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Bourgeois, A. Alexiu, and D. Lemonnier, “Dietary-induced obesity: effect of dietary fats on adipose tissue cellularity in mice,” British Journal of Nutrition, vol. 49, no. 1, pp. 17–26, 1983. View at Publisher · View at Google Scholar · View at Scopus
  46. X. Wu, H. Motoshima, K. Mahadev, T. J. Stalker, R. Scalia, and B. J. Goldstein, “Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes,” Diabetes, vol. 52, no. 6, pp. 1355–1363, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe, “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1784–1792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Kadowaki and T. Yamauchi, “Adiponectin and adiponectin receptors,” Endocrine Reviews, vol. 26, no. 3, pp. 439–451, 2005. View at Publisher · View at Google Scholar · View at Scopus